Immune Activation Assay
Immune Activation Assay - Related Videos
01:31
Active versus Passive Immunity
0 Views •
2024
Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices. Active Immunity Active immunity refers to the resistance one develops...
08:45
Assay for Pathogen-Associated Molecular Pattern (PAMP)-Triggered Immunity (PTI) in Plants
0 Views •
Cited by 23 •
2009
A cell death-based assay for PTI in Nicotiana benthamiana plants is described.
03:35
Flow Cytometry-Based Analysis of Dendritic Cell Activation Using Immune Complexes
0 Views •
2025
This video demonstrates a protocol for assessing the activation of dendritic cells using immunoglobulin G (IgG)-coated tumor cells. Dendritic cells internalize the IgG-coated tumor cells, process the tumor antigens, and present them on the surface through MHC-II molecules, along with the co-expression of the costimulatory molecule CD86. These dendritic cells then undergo MHC-II and CD86-targeted immunostaining and flow cytometry analysis to identify their activation state.
05:42
A Barcoding Assay for Phenotypic and Functional Characterization of Immune Cells
0 Views •
2025
This video highlights a single-cell proteomic method that employs heavy-metal-conjugated antibodies for distinct cell barcoding. Subsequently, immunostaining and mass cytometry are applied to evaluate immune phenotypic and functional alterations in human whole blood-derived immune cells.
04:25
Endotoxin Activity Assay: A Chemiluminescence-Based Bioassay for Investigating Endotoxin Activity in Blood Sample
0 Views •
2025
This video demonstrates a rapid bioassay for investigating endotoxin activity in a whole blood sample via a chemiluminescence-based method. This assay is a rapid and sensitive biomarker test for early-stage diagnosis of endotoxin-mediated sepsis.
FAQs
The stimulus determines the immune response being challenged and therefore frames how the result should be interpreted. Antigens and pathogen-derived components model signals associated with infectious exposure, whereas mitogens provide a broader activation stimulus. Using a defined input lets investigators compare how immune cells respond across conditions, including health, disease, or treatment settings.
Cytokine release, cell proliferation, and activation-marker expression represent distinct measurable changes after stimulation. Measuring one or more of these outputs can show whether the response is reflected in secreted signals, cellular expansion, or altered activation state. This distinction helps investigators characterize immune function rather than relying on a single indicator of activity.
An immune activation assay is functional because it examines what immune cells do after exposure to a defined challenge. The relevant evidence is a change in cytokine release, proliferation, or activation-marker expression, not merely the presence of cells. This approach can reveal differences in immune cell performance between health and disease.
During infection, measured immune-cell changes can connect a defined stimulus with inflammatory activity. Cytokine release provides an indicator of secreted immune signaling, while proliferation or activation-marker changes show other cellular responses. Examining these outcomes helps clarify mechanisms of inflammation and supports comparisons of host responses in different disease-related settings.
A basic workflow starts with selecting immune cells and a defined stimulus, such as an antigen, pathogen-derived component, or mitogen. The cells are exposed to that stimulus under the assay conditions, after which investigators evaluate cytokine release, proliferation, activation-marker expression, or a combination of these outcomes. The selected readout should match the response being characterized.
These assays help assess the effects of vaccines and immunomodulatory treatments by measuring cellular responses to defined stimulation. Changes in cytokine release, proliferation, or activation-marker expression can indicate how immune activity differs across tested conditions. The resulting functional information supports investigation of treatment effects and may guide therapeutic or preventive strategy development.
Researchers can apply the same general measurement framework to cells from different health or disease contexts, then compare their responses to a defined stimulus. Differences in cytokine release, proliferation, or activation-marker expression provide a functional basis for characterizing host responses. This comparison is useful when infection or disease may alter immune activity.
Results can contribute to diagnostic, therapeutic, and preventive research by showing how immune cells react to relevant stimulation. In immunology and infection, this information can help characterize host responses, investigate inflammatory mechanisms, and evaluate effects of vaccines or immunomodulatory treatments. The assay therefore links cellular measurements with broader questions about disease and intervention.